{"organizations": [], "uuid": "594bba42dc273fbce7e07df9dee3dacfb23762bc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/30/pr-newswire-varian-to-discuss-agreement-to-acquire-sirtex.html", "country": "US", "domain_rank": 767, "title": "Varian to Discuss Agreement to Acquire Sirtex", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T10:04:00.000+02:00", "replies_count": 0, "uuid": "594bba42dc273fbce7e07df9dee3dacfb23762bc"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/30/pr-newswire-varian-to-discuss-agreement-to-acquire-sirtex.html", "ord_in_thread": 0, "title": "Varian to Discuss Agreement to Acquire Sirtex", "locations": [], "entities": {"persons": [{"name": "varian", "sentiment": "negative"}, {"name": "varian varian", "sentiment": "none"}], "locations": [{"name": "sirtex palo alto", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "palo alto", "sentiment": "none"}, {"name": "california", "sentiment": "none"}], "organizations": [{"name": "nyse", "sentiment": "negative"}, {"name": "sirtex medical limited", "sentiment": "none"}, {"name": "australian securities exchange", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today , to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) (\"Sirtex\"). Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is listed on the Australian Securities Exchange.\nThe conference call and webcast will start at 9:00 a.m. ET on Tuesday, January 30, 2018. To access the teleconference call and replay:\nTeleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261.\nWebcast: The live webcast and replay will be available on the Varian Investor Relations website at www.varian.com/investors .\nAbout Varian\nVarian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.\nInvestor Relations Contact\nJ. Michael Bruff\nVice President, Investor Relations\n+1 (650) 424-5163\nmike.bruff@varian.com\nPress Contact\nMark Plungy\nDirector, Public Relations\n+1 (650) 424-5630\nmark.plungy@varian.com\nView original content: http://www.prnewswire.com/news-releases/varian-to-discuss-agreement-to-acquire-sirtex-300590021.html\nSOURCE Varian", "external_links": ["http://www.varian.com/", "https://www.prnewswire.com/news-releases/varian-signs-agreement-to-acquire-sirtex-300590018.html", "http://www.varian.com/investors", "http://www.prnewswire.com/news-releases/varian-to-discuss-agreement-to-acquire-sirtex-300590021.html"], "published": "2018-01-30T10:04:00.000+02:00", "crawled": "2018-01-30T10:28:10.014+02:00", "highlightTitle": ""}